1-3 of 3
Zhihong Zhang
Close
Sort by
Journal Articles

Focal Adhesion Kinase Inhibitors Reverse the Stromal Adhesion Phenotype of Ikaros-Mutant B-ALL, Induce Apopotosis, and Synergize with ABL1 Tyrosine Kinase Inhibitors: A New Paradigm for Pathogenesis and Therapy of High-Risk B-ALL

Ila Joshi, PhD, Nilamani Jena, PhD, Toshimi Yoshida, PhD, Leto Paraskevopoulou, BS, Zhihong Zhang, PhD, Zhong-Ying Liu, MDPhD, Shane Korber, Daniela S. Krause, MD, Irina M. Shapiro, PhD, David T. Weaver, PhD, Jonathan A. Pachter, PhD, Elisabeth M. Paietta, PhD, Richard A. Van Etten, MDPhD, Katia Georgopoulos, PhD
Journal: Blood
Blood (2014) 124 (21): 285.
https://doi.org/10.1182/blood.V124.21.285.285
Published: 2014
Journal Articles

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3034.
https://doi.org/10.1182/blood.V122.21.3034.3034
Published: 2013
Journal Articles

Clinical Study Of Dose-Adjusted EPOCH Regimen For Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis: Preliminary Results Of An Ongoing Phase II Study

Wei Xu, MD, PhD, Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4360.
https://doi.org/10.1182/blood.V122.21.4360.4360
Published: 2013